These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Crystal Structure of Cytochrome P450 (CYP105P2) from Streptomyces peucetius and Its Conformational Changes in Response to Substrate Binding. Lee CW; Lee JH; Rimal H; Park H; Lee JH; Oh TJ Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231902 [TBL] [Abstract][Full Text] [Related]
5. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium. Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671 [TBL] [Abstract][Full Text] [Related]
6. What Your Crystal Structure Will Not Tell You about Enzyme Function. Pochapsky TC; Pochapsky SS Acc Chem Res; 2019 May; 52(5):1409-1418. PubMed ID: 31034199 [TBL] [Abstract][Full Text] [Related]
7. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations. Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175 [TBL] [Abstract][Full Text] [Related]
8. Structural insights into understudied human cytochrome P450 enzymes. Machalz D; Pach S; Bermudez M; Bureik M; Wolber G Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845 [TBL] [Abstract][Full Text] [Related]
9. Ligand Access Channels in Cytochrome P450 Enzymes: A Review. Urban P; Lautier T; Pompon D; Truan G Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848998 [TBL] [Abstract][Full Text] [Related]
10. Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back. Halpert JR Drug Metab Dispos; 2011 Jul; 39(7):1113-21. PubMed ID: 21502194 [TBL] [Abstract][Full Text] [Related]
11. Molecular Dynamics Simulations of a Cytochrome P450 from Faponle AS; Roy A; Adelegan AA; Gauld JW Molecules; 2021 Jun; 26(12):. PubMed ID: 34204747 [TBL] [Abstract][Full Text] [Related]
12. A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment. Fischer A; Smieško M Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948012 [TBL] [Abstract][Full Text] [Related]
16. Identifying cytochrome p450 functional networks and their allosteric regulatory elements. Liu J; Tawa GJ; Wallqvist A PLoS One; 2013; 8(12):e81980. PubMed ID: 24312617 [TBL] [Abstract][Full Text] [Related]
17. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6. Martiny VY; Carbonell P; Chevillard F; Moroy G; Nicot AB; Vayer P; Villoutreix BO; Miteva MA Bioinformatics; 2015 Dec; 31(24):3930-7. PubMed ID: 26315915 [TBL] [Abstract][Full Text] [Related]
18. Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62. Fukuyoshi S; Kometani M; Watanabe Y; Hiratsuka M; Yamaotsu N; Hirono S; Manabe N; Takahashi O; Oda A PLoS One; 2016; 11(4):e0152946. PubMed ID: 27046024 [TBL] [Abstract][Full Text] [Related]
19. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle. Yoon MY; Campbell AP; Atkins WM Drug Metab Rev; 2004 May; 36(2):219-30. PubMed ID: 15237852 [TBL] [Abstract][Full Text] [Related]
20. Advances in molecular modeling of human cytochrome P450 polymorphism. Martiny VY; Miteva MA J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]